Our Solutions

newsletter

NEWSLETTER

  • Newsletter

    June 2014

    Jun 1, 2014

    Customize in Real-Time: First-In-Human (FIH) Trial Gantt Chart, Webinar Recording Available and 2014 CSPS Annual Conference Recordings.

  • Newsletter

    May 2014

    May 1, 2014

    CSPS 2014 Annual Conference, Discover the Latest Large Molecule Bioanalytical Advancements, Complimentary Webinar - June 4th: Criteria for Performing a Scientifically Meaningful Lipemic Plasma Test during LC-MS/MS Bioanalytical Method Validation: Which Type to Choose?, Join us for the DIA Poster Presentations and 2014 ASMS Conference.

  • Newsletter

    April 2014

    Apr 1, 2014

    Webinar: Criteria for Performing a Scientifically Meaningful Lipemic Plasma Test during LC-MS/MS Bioanalytical Method Validation: Which Type to Choose?, Algorithme Pharma Receives the 2014 CRO Leadership Award and AAPS National Biotechnology Conference.

  • Newsletter

    March 2014

    Mar 1, 2014

    Industry Recognizes Algorithme Pharma as Preeminent CRO that Surpasses Sponsor Expectations and Provides Greater Value, Pharmacogenetics in Early Stage Clinical Trials: Accelerating Drug Characterization for Improved Development Outcomes, See for yourself, take a 360° Tour of our Clinic Expansion, An Invitation to attend the Spring 2014 CPDG Meeting and See Our March Conference Poster Presentations.

  • Newsletter

    February 2014

    Feb 1, 2014

    Science Exchange Symposium—Partnerships & Strategies for Efficient Drug Development in Quebec, SOT 2014 Annual Meeting—Register for a Complimentary Breakfast & Speaking Session, Eliminating Incurred Sample Reanalysis (ISR) Evaluation Failures and Webinar: PEGylated proteins quantification strategies by LC-MS/MS.

  • Newsletter

    Eliminating Incurred Sample Reanalysis (ISR) Evaluation Failures

    Feb 1, 2014

    Algorithme Pharma has developed the Bioanalytical expertise to eliminate ISR evaluation failures by addressing key considerations in the early stages of method development. Our reproducible methods allow sponsors to meet the regulatory guidance requirements and avoid unnecessary repeat analyses.

  • Newsletter

    January 2014

    Jan 1, 2014

    Algorithme Pharma Expands Montréal Clinic with New Unit, Algorithme Pharma Gains Key Patient Access Through Partnership with Hôpital Maisonneuve-Rosemont (HMR), Pharmacokinetic, Adhesion and Safety Evaluation of Transdermal Patches and Early Stage Decisions Made Easier with Effective Tissue Bioanalysis.

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.